本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Corvus Pharmaceuticals, Inc.

8.91
-0.0050-0.06%
成交量:22.72萬
成交額:202.13萬
市值:6.65億
市盈率:-15.94
高:9.07
開:8.70
低:8.69
收:8.91
52周最高:9.55
52周最低:2.54
股本:7,468.19萬
流通股本:5,735.63萬
量比:0.68
換手率:0.40%
股息:- -
股息率:- -
每股收益(TTM):-0.5587
每股收益(LYR):-1.0214
淨資產收益率:-35.82%
總資產收益率:-34.87%
市淨率:9.27
市盈率(LYR):-8.72

資料載入中...

2022/08/08

重要事件披露

8-K - Current report
2022/08/08

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/06/17

重要事件披露

8-K - Current report
2022/05/05

重要事件披露

8-K - Current report
2022/05/05

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/05

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/10

重要事件披露

8-K - Current report
2022/03/10

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/18

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/06

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/03

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/11/02

重要事件披露

8-K - Current report
2021/11/01

重要事件披露

8-K - Current report
2021/11/01

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/10/22

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/10/05

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals